Journal of the American Pharmacists Association Impact Factor & Information

Publisher: American Pharmacists Association

Journal description

The Journal of the American Pharmacists Association, the official peer-reviewed journal of the American Pharmacists Association, provides members with articles and columns on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research.

Current impact factor: 1.24

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 1.238

Additional details

5-year impact 1.35
Cited half-life 8.30
Immediacy index 0.28
Eigenfactor 0.00
Article influence 0.35
Website Journal of the American Pharmacists Association: JAPhA website
Other titles Journal of the American Pharmacists Association (1996: Online), Journal of the American Pharmacists Association, JAPhA
ISSN 1544-3450
OCLC 52032194
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publications in this journal

  • Journal of the American Pharmacists Association 09/2015; 55(5):568. DOI:10.1331/JAPhA.2015.15538
  • Journal of the American Pharmacists Association 09/2015; 55(5):470-476. DOI:10.1331/JAPhA.2015.15535
  • Journal of the American Pharmacists Association 09/2015; 55(5):560-562. DOI:10.1331/JAPhA.2015.15536
  • Journal of the American Pharmacists Association 09/2015; 55(5):478-480. DOI:10.1331/JAPhA.2015.15057
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To determine the number of discrepancies and medication-related problems found as a result of pharmacy-led medication reconciliation involving introductory pharmacy practice experience (IPPE) students at a comprehensive cancer center. Setting: Outpatient infusion center of a National Cancer Institute (NCI)-designated and National Comprehensive Cancer Network (NCCN) cancer center. Practice description and innovation: Third-year IPPE students contacted and completed medication reconciliation for 510 hematology/oncology patients scheduled for infusion center appointments without a coupled provider visit. IPPE students discussed the findings of the medication reconciliations with their pharmacist preceptors, who updated the medication histories in the electronic medical record (EMR) and communicated with prescribers directly about identified medication-related problems. All medication reconciliation was documented using a standardized note template in the EMR. Main outcome measures: Number of medication discrepancies found, including medication additions, medication deletions, dose changes, and herbal product additions; medication-related problems-including drug-drug interactions, untreated indications (e.g., nausea, vomiting, pain, need for prophylactic medications), failure of patients to receive prescribed medications, and adverse drug reactions-were also documented. Results: Medication reconciliation was completed for 510 patients through the student pharmacist/pharmacist preceptor-led intervention during a 1-year period between January 1, 2013, and December 31, 2013. A total of 88% of patients had at least one discrepancy identified in their medication history and corrected in the EMR. In addition, 11.4% of patients had a medication-related problem identified. Conclusions: Pharmacy-led medication reconciliation identified a large number of discrepancies among our hematology/oncology patients. This intervention allowed for correction of discrepancies in the EMR leading to improved accuracy of patient medication lists. In addition, it provided a valuable learning experience for student pharmacists.
    Journal of the American Pharmacists Association 09/2015; 55(5):540-545. DOI:10.1331/JAPhA.2015.14214
  • Journal of the American Pharmacists Association 09/2015; 55(5):468. DOI:10.1331/JAPhA.2015.15032
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To improve understanding of the logistics of transitions of care (TOC) clinics and to provide guidance to pharmacists in developing and implementing a new TOC clinic or improving an existing one. Setting: Outpatient TOC clinic within an ambulatory care practice. Practice description: Two general internal medicine practices collaborated with a university health system to create an interdisciplinary TOC clinic to improve quality and continuity of patient care. The clinic accommodates any patients of the practice who are not able to get an appointment with their primary care physician within 1 to 2 weeks of discharge from any hospital. Physician residents, an attending physician, a clinical pharmacist, a nurse, medical assistants, and a social worker (if necessary) are involved in the patient's care during the transition process. Practice innovation: Pharmacists can play a vital role in developing and implementing a TOC clinic or enhancing a current one. There are many logistical components to consider in developing a clinic, and this article provides guidance in the various steps required in creating a clinic, including support and coordination, personnel, workflow, operations, reimbursement, marketing, metrics, and measures. Conclusion: This tool may help pharmacists implement or enhance an outpatient TOC clinic to improve patient care, quality, and continuity.
    Journal of the American Pharmacists Association 09/2015; 55(5):527-533. DOI:10.1331/JAPhA.2015.14278
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To evaluate pharmacy staff perspectives of a 2-year pharmacy intervention aimed at reducing unintended pregnancy in 18- to 30-year-old women. Design: Pharmacy staff completed a 48-item, self-administered paper survey consisting of scaled and open-ended questions. Setting: 55 community pharmacies in 12 Iowa counties. Participants: All pharmacy staff participated, including pharmacists, pharmacy technicians, and other pharmacy employees. Intervention: Online continuing education (CE) training was made available to all pharmacy staff. Promotional materials including posters, brochures, and shelf talkers were displayed in all of the pharmacies. Main outcome measures: Pharmacy staff perceptions and self-reported behaviors related to displaying posters, brochures, and shelf talkers in their pharmacies and providing contraceptive information and counseling to patients/customers. Results: A total of 192 (43% return rate) pharmacy staff responded. Only 44% of respondents consistently provided contraceptive information and counseling, yet more than 90% felt that talking with patients/customers about contraceptives was easy, and more than 50% could do so privately. The study showed increased pharmacy staff desire to make this topic a priority. Conclusion: Community pharmacy staff can play a key role in educating and counseling young adult women about contraceptive health and pregnancy planning. This study indicates that staff are comfortable providing this service and that patients/customers are open to receiving guidance from pharmacists. However, pharmacy staff are missing additional opportunities to provide information and counseling. There is also a need for greater attention to provision of nonprescription contraceptive education.
    Journal of the American Pharmacists Association 09/2015; 55(5):481-487. DOI:10.1331/JAPhA.2015.15037
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To assess participant satisfaction with a community pharmacy-based medication synchronization program. Setting: A single location of a grocery store pharmacy chain in the Kansas City metropolitan area. Practice description: A medication synchronization program, Time My Meds (TMM), was implemented in 1 of 20 community pharmacies within the grocery store chain. Practice innovation: Current pharmacy patients taking three or more chronic medications were recruited to enroll in the medication synchronization program. After at least 3 months of enrollment in TMM, participants were invited to complete a paper survey to assess satisfaction with the program. Evaluation: Data were collected on overall participant satisfaction with the TMM program. A 10-statement survey gathered demographic information and assessed participant satisfaction using a 5-point Likert scale (1, strongly disagree, to 5, strongly agree). Results: Data collected from 48 surveys were analyzed. No statistical differences in participant satisfaction were found when considering age, education, income, number of medications at pick-up, or number of monthly trips to the pharmacy prior to program enrollment. Median scores for individual survey items were all 5 out of 5 (strongly agree) using a 5-point Likert scale. Conclusion: Participants were highly satisfied with the medication synchronization program. These results, if expanded to a wider population, might provide valuable information for continued justification and implementation of this type of service in community pharmacies.
    Journal of the American Pharmacists Association 09/2015; 55(5):534-539. DOI:10.1331/JAPhA.2015.14242
  • Journal of the American Pharmacists Association 09/2015; 55(5):563-567. DOI:10.1331/JAPhA.2015.15537
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To compare the immediate postcounseling retention of important information using the traditional method with retention obtained using the Indian Health Service (IHS) interactive technique, and to compare the time required to counsel patients on new prescriptions using the traditional method with the time required using the IHS technique. Design: A prospective, nonrandomized, observational study at four different local community pharmacies in Oregon. Two sites that used the traditional counseling model served as the control sites, while two other sites used the IHS counseling model. Only new prescriptions were included in this study. The pharmacists did not alter their counseling styles for new prescriptions for the purposes of this study. The duration of counseling between the pharmacist and patient was recorded. Immediately upon completion of counseling, patients met with the primary investigator for postcounseling knowledge assessment on indication of therapy, directions on how to take their medication properly, and expected adverse effects. Setting: Four local community pharmacies in Oregon. Participants: Five hundred patients at four local community pharmacies in Oregon. Intervention: Use of the IHS counseling technique. Main outcome measures: Immediate recall of key counseling points and time per counseling session. Results: A total of 500 patients participated in the study. Seventy-one percent of patients counseled using the IHS technique answered all three questions correctly, compared with 33% of patients counseled using the traditional method (P <0.00). For patients who were counseled about adverse effects, 80% counseled using the IHS technique compared with 51.5% counseled using the traditional approach answered all three questions correctly. For indication of therapy, there was no evidence of a difference in the proportion of correct answers between counseling types on the reason for taking their medication (P = 0.06). Those who received IHS counseling had four times the odds of correctly answering when to take their medication and four times the odds of correctly answering all adverse effects questions. The duration of counseling methods differed by 53 seconds (128 s for IHS vs. 75 s for traditional). Conclusion: The interactive style of the IHS method of counseling provided significantly improved immediate memory recall compared with the traditional method. The IHS method also took longer than the traditional method.
    Journal of the American Pharmacists Association 09/2015; 55(5):503-510. DOI:10.1331/JAPhA.2015.14093
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To assess clinical outcomes (glycosylated hemoglobin [A1C], blood pressure, and lipids) and other measurements (disease state knowledge, adherence, and self-efficacy) associated with the use of approved telemonitoring devices to expand and improve chronic disease management of patients with diabetes, with or without hypertension. Setting: Four community health centers (CHCs) in Utah. Practice description: Federally qualified safety net clinics that provide medical care to underserved patients. Practice innovation: Pharmacist-led diabetes management using telemonitoring was compared with a group of patients receiving usual care (without telemonitoring). Interventions: Daily blood glucose (BG) and blood pressure (BP) values were reviewed and the pharmacist provided phone follow-up to assess and manage out-of-range BG and BP values. Evaluation: Changes in A1C, BP, and low-density lipoprotein (LDL) at approximately 6 months were compared between the telemonitoring group and the usual care group. Patient activation, diabetes/hypertension knowledge, and medication adherence were measured in the telemonitoring group. Results: Of 150 patients, 75 received pharmacist-provided diabetes management and education via telemonitoring, and 75 received usual medical care. Change in A1C was significantly greater in the telemonitoring group compared with the usual care group (2.07% decrease vs. 0.66% decrease; P <0.001). Although BP and LDL levels also declined, differences between the two groups were not statistically significant. Patient activation measure, diabetes/hypertension knowledge, and medication adherence with antihypertensives (but not diabetes medications) improved in the telemonitoring group. Conclusion: Pharmacist-provided diabetes management via telemonitoring resulted in a significant improvement in A1C in federally qualified CHCs in Utah compared with usual medical care. Telemonitoring may be considered a model for providing clinical pharmacy services to patients with diabetes.
    Journal of the American Pharmacists Association 09/2015; 55(5):516-526. DOI:10.1331/JAPhA.2015.14285
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To document the cost of implementing point-of-care (POC) human immunodeficiency virus (HIV) rapid testing in busy community pharmacies and retail clinics. Providing HIV testing services in community pharmacies and retail clinics is an innovative way to expand HIV testing. The cost of implementing POC HIV rapid testing in a busy retail environment needs to be documented to provide program and policy leaders with adequate information for planning and budgeting. Design: Cost analysis from a pilot project that provided confidential POC HIV rapid testing services in community pharmacies and retail clinics. Setting: The pharmacy sites were operated under several different ownership structures (for-profit, nonprofit, sole proprietorship, corporation, public, and private) in urban and rural areas. We included data from the initial six sites that participated in the project. We collected the time spent by pharmacy and retail clinic staff for pretest and posttest counseling in an activity log for time-in-motion for each interaction. Participants: Pharmacists and retail clinic staff. Intervention: HIV rapid testing. Main outcome measures: The total cost was calculated to include costs of test kits, control kits, shipping, test supplies, training, reporting, program administration, and advertising. Results: The six sites trained 22 staff to implement HIV testing. A total of 939 HIV rapid tests were conducted over a median time of 12 months, of which 17 were reactive. Median pretest counseling time was 2 minutes. Median posttest counseling time was 2 minutes for clients with a nonreactive test and 10 minutes for clients with a reactive test. The average cost per person tested was an estimated $47.21. When we considered only recurrent costs, the average cost per person tested was $32.17. Conclusions: Providing POC HIV rapid testing services required a modest amount of staff time and costs that are comparable to other services offered in these settings. HIV testing in pharmacies and retail clinics can provide an additional alternative venue for increasing the availability and accessibility of HIV testing services in the United States.
    Journal of the American Pharmacists Association 09/2015; 55(5):488-492. DOI:10.1331/JAPhA.2015.150630
  • [Show abstract] [Hide abstract]
    ABSTRACT: To describe and apply a model for combining self-assessed frequency and criticality for pharmacy technicians' roles and to evaluate similarities and differences between attitudes toward public safety in various practice settings. Cross-sectional mail survey of randomly selected pharmacy technicians in one state. Iowa in fall 2012. 1,000 registered technicians. Mail survey with option for online completion. Scored ratings related to perceptions of frequency and criticality of roles. Technicians rated role frequency on a scale from 1 (not responsible) to 6 (daily) and role criticality on a scale from 1 (no importance) to 4 (extremely important). A weighted relative importance score was ranked to show importance of the role considering frequency and criticality together. The response rate was 25.81%. Ratings for frequency were correlated to ratings for criticality for 22 of 23 roles. A Mann-Whitney U test found a difference between ambulatory technicians and hospital technicians. A visual matrix of a dual-scaled analysis showed both groups' role ratings to be positively linearly related. Hospital technicians showed wider discrimination in their ratings for some roles than for others. Perceived role frequency and criticality can be considered together to contextualize the practice environment. The data suggest a relationship between perceived frequency of role performed and perception of a role's criticality. The study found differences between how technicians from various practice settings perceive their roles.
    Journal of the American Pharmacists Association 09/2015; DOI:10.1331/JAPhA.2015.15010
  • [Show abstract] [Hide abstract]
    ABSTRACT: To highlight the limitations of community pharmacy practice and to propose a system change by implementing a risk-assessment method and management strategy for opioids in this arena. Selected by the author. Numerous studies show that the U.S. health care system is subject to a high rate of drug misadventures involving primarily low therapeutic index drugs, especially opioids. Currently proposed approaches to managing opioids focus on access control, but without a broader consideration of patient-use problems that lead to morbidity and mortality. While pharmacists are well-trained health professionals, their primary focus has been on drug distribution rather than proper use. This article highlights the limitations in contemporary community pharmacy practice that likely contribute to the problem of opioid misuse and resultant morbidity. A new model of practice is proposed whereby the most dangerous agents such as opioids are preidentified for a more formalized risk-based strategy focused upon optimal patient education and required follow-up.
    Journal of the American Pharmacists Association 07/2015; 55(5):e377-e379. DOI:10.1331/JAPhA.2015.14286
  • [Show abstract] [Hide abstract]
    ABSTRACT: To describe the impact of a pharmacist-run antiarrhythmic clinic in an outpatient practice. Blanchard Valley Medical Associates (BVMA) in Findlay, OH. BVMA is a 15-physician private practice with five pharmacists on staff who run several disease management clinics. Patients receiving amiodarone or sotalol are referred to a pharmacist-run antiarrhythmic clinic within an outpatient physicians' office. The pharmacist is responsible for coordinating, monitoring, and reviewing results with patients. A retrospective chart review was conducted to compare adherence to monitoring protocols between patients referred to the pharmacist-run clinic and patients managed solely by physicians, and to evaluate the type and frequency of pharmacist-initiated interventions. Patients had received antiarrhythmic treatment for at least 6 months before the beginning of the retrospective review. A total of 130 patient charts were reviewed. Adherence for each recommended testing parameter for patients on amiodarone and sotalol was significantly higher among patients managed by a pharmacist compared with usual care. A total of 62 adverse events were detected and 39 interventions were made by the pharmacist group. Patients with pharmacist monitoring of outpatient antiarrhythmic medications had greater adherence to recommended testing protocols compared with usual care.
    Journal of the American Pharmacists Association 07/2015; 55(5):e381-e386. DOI:10.1331/JAPhA.2015.14260
  • Journal of the American Pharmacists Association 07/2015; 55(4):461-463. DOI:10.1331/JAPhA.2015.15523
  • Journal of the American Pharmacists Association 07/2015; 55(4):457-460. DOI:10.1331/JAPhA.2015.15522
  • Journal of the American Pharmacists Association 07/2015; 55(4):464. DOI:10.1331/JAPhA.2015.15524